Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Na+/H+ exchange inhibitors claimed for ischemic and other disorders by Hoechst

May 14, 1998

HRT more effective than raloxifene in improving heart disease risk factors

May 13, 1998

Promising new TMR data presented at scientific meeting

May 13, 1998

Merck KGaA, Yamanouchi to codevelop two new cardiovascular drug candidates

May 13, 1998

MK-886 demonstrates antihyperplastic activity in an animal model of intimal thickening

May 13, 1998

Azimilide: a unique new antiarrhythmic agent in phase III development

May 12, 1998

Roche and Nortran join forces for development of atrial arrhythmia drugs

May 11, 1998

Proteus seeks partners, licensees for novel hypertension vaccine

May 8, 1998

Roche now copromoting Coreg with SKB

May 8, 1998

E-4010: a potential new treatment for pulmonary hypertension

May 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...